Thermo Fisher Scientific has reported that its revenues increased 1% to a record $2.65 billion in the fourth quarter of 2008, compared with $2.62 billion the previous year. For the whole year revenues grew 8% to a record $10.5 billion compared with $9.75 billion previously.
Thermo Fisher Scientific has reported that its revenues increased 1% to a record $2.65 billion in the fourth quarter of 2008, compared with $2.62 billion the previous year. For the whole year revenues grew 8% to a record $10.5 billion compared with $9.75 billion previously.
“We are pleased to report very solid financial results for both the fourth quarter and the full year in spite of the economic headwinds that continue to put pressure on capital spending in some of our end markets,” said Marijn E. Dekkers, president and chief executive officer of the company. “Our performance is largely the result of our favorable product mix, with two-thirds of our revenues coming from recurring sales of consumables and services that tend to hold up better in an uncertain environment.”
Dekkers also predicted how the company would perform in the coming year; “The economic climate will likely continue to restrain capital budgets, especially through the first half of the year. Based on that assumption, and a negative impact of approximately 4% from foreign exchange, we expect to achieve 2009 revenues of $10.0 to $10.3 billion, or a 2 to 5% decline compared with 2008.”
Visit the company’s website, www.thermofisher.com to access more detailed financial reports.
Traditional Chinese Medicine’s Effects on Liver Cancer Measured Using New UHPLC–QTOF-MS System
April 22nd 2024Scientists from Anhui University of Chinese Medicine in Hefei, China recently investigated the mechanisms behind what makes huachansu tablets, a type of traditional Chinese medicine (TCM), effective against liver cancer.